65-4107. Substances included in schedule II. (a) The controlled substances listed in this section are included in schedule II and the number set forth opposite each drug or substance is the DEA controlled substances code which has been assigned to it.

(b) Any of the following substances, except those narcotic drugs listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin or independently by means of chemical synthesis or by combination of extraction and chemical synthesis:

(1) Opium and opiate and any salt, compound, derivative or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone and naltrexone and their respective salts, but including the following:

(A)  Raw opium  9600

(B)  Opium extracts  9610

(C)  Opium fluid  9620

(D)  Powdered opium  9639

(E)  Granulated opium  9640

(F)  Tincture of opium  9630

(G)  Codeine  9050

(H)  Ethylmorphine  9190

(I)  Etorphine hydrochloride  9059

(J)  Hydrocodone  9193

(K)  Hydromorphone  9150

(L)  Metopon  9260

(M)  Morphine  9300

(N)  Oxycodone  9143

(O)  Oxymorphone  9652

(P)  Thebaine  9333

(Q)  Dihydroetorphine  9334

(R)  Oripavine  9330

(2) Any salt, compound, isomer, derivative or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium.

(3) Opium poppy and poppy straw.

(4) Coca leaves (9040) and any salt, compound, derivative or preparation of coca leaves, but not including decocainized coca leaves or extractions which do not contain cocaine (9041) or ecgonine (9180).

(5) Cocaine, its salts, isomers and salts of isomers (9041).

(6) Ecgonine, its salts, isomers and salts of isomers (9180).

(7) Concentrate of poppy straw (the crude extract of poppy straw in either liquid, solid or powder form which contains the phenanthrene alkaloids of the opium poppy) (9670).

(c) Any of the following opiates, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation dextrorphan and levopropoxyphene excepted:

(1)  Alfentanil  9737

(2)  Alphaprodine  9010

(3)  Anileridine  9020

(4)  Bezitramide  9800

(5)  Bulk dextropropoxyphene (nondosage forms)  9273

(6)  Carfentanil  9743

(7)  Dihydrocodeine  9120

(8)  Diphenoxylate  9170

(9)  Fentanyl  9801

(10)  Isomethadone  9226

(11)  Levomethorphan  9210

(12)  Levorphanol  9220

(13)  Metazocine  9240

(14)  Methadone  9250

(15)  Methadone-intermediate,4-cyano-2-dimethyl amino-4,4-diphenyl butane  9254

(16)  Moramide-intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid  9802

(17)  Pethidine (meperidine)  9230

(18)  Pethidine-intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine  9232

(19)  Pethidine-intermediate-B, ethyl-4-phenyl-piperidine-4-carboxylate  9233

(20)  Pethidine-intermediate-C, 1-methyl-4-phenyl-piperidine-4-carboxylic acid  9234

(21)  Phenazocine  9715

(22)  Piminodine  9730

(23)  Racemethorphan  9732

(24)  Racemorphan  9733

(25)  Sufentanil  9740

(26)  Levo-alphacetyl methadol  9648Some other names: levo-alpha-acetyl methadol, levomethadyl acetate or LAAM.

(27)  Remifentanil  9739

(28)  Tapentadol  9780

(29)  Thiafentanil  9729

(d) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

(1)  Amphetamine, its salts, optical isomers and salts of its optical isomers  1100

(2)  Phenmetrazine and its salts  1631

(3)  Methamphetamine, including its salts, isomers and salts of isomers  1105

(4)  Methylphenidate  1724

(5)  Lisdexamfetamine, its salts, isomers, and salts of its isomers    1205

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)  Amobarbital  2125

(2)  Glutethimide  2550

(3)  Secobarbital  2315

(4)  Pentobarbital  2270

(5)  Phencyclidine  7471

(f) Any material, compound, mixture, or preparation which contains any quantity of the following substances:

(1)  Immediate precursor to amphetamine and methamphetamine:

(A)  Phenylacetone  8501Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone.

(2)  Immediate precursors to phencyclidine (PCP):

(A)  1-phenylcyclohexylamine  7460

(B)  1-piperidinocyclohexanecarbonitrile (PCC)  8603

(3)  Immediate precursor to fentanyl:

(A)  4-anilino-N-phenethyl-4-piperidine (ANPP)  8333

(g) Any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substance, its salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

(1)  Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the United States food and drug administration  7365

(2)  Nabilone  7379

[Another name for nabilone: (±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one]

(h) Any material, compound, mixture or preparation containing any of the following narcotic drugs or any salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

(1)  Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with a fourfold or greater quantity of an isoquinoline alkaloid of opium  9805

(2)  Not more than 300 milligrams of dihydrocodeinone (hydrocodone) or any of its salts per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active, nonnarcotic ingredients in recognized therapeutic amounts  9806

History: L. 1972, ch. 234, § 7; L. 1974, ch. 258, § 3; L. 1978, ch. 257, § 1; L. 1980, ch. 195, § 2; L. 1982, ch. 269, § 3; L. 1985, ch. 220, § 2; L. 1986, ch. 241, § 2; L. 1987, ch. 244, § 2; L. 1989, ch. 200, § 2; L. 1991, ch. 199, § 2; L. 1992, ch. 174, § 2; L. 1994, ch. 54, § 2; L. 2000, ch. 108, § 2; L. 2011, ch. 83, § 4; L. 2015, ch. 27, § 2; L. 2017, ch. 57, § 5; L. 2018, ch. 101, § 2; May 24.